<table id="_Refid_5c6acfe0-58d1-4ffe-a079-ac1d32904" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 6. Drugs That Should Not Be Coadministered With RESCRIPTOR</caption>
<col width="33%"></col>
<col width="68%"></col>
<tbody>
<tr>
<td align="center" stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>Drug Class: Drug Name</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Toprule " valign="top">
<paragraph>Clinical Comment</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">Anticonvulsant agents:</content>
</paragraph>
<paragraph>Phenytoin, phenobarbital, carbamazepine</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>May lead to loss of virologic response and possible resistance to RESCRIPTOR or to the class of NNRTIs.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">Antihistamines:</content>
</paragraph>
<paragraph>Astemizole, terfenadine</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">Antimycobacterials: </content>
</paragraph>
<paragraph>Rifabutin,<sup>a</sup> rifampin<sup> a</sup>
</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>May lead to loss of virologic response and possible resistance to RESCRIPTOR or to the class of NNRTIs or other coadministered antiviral agents.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">Ergot Derivatives:</content>
</paragraph>
<paragraph>Dihydroergotamine, ergonovine, ergotamine, methylergonovine</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">GI motility agent:</content>
</paragraph>
<paragraph>Cisapride</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">Herbal Products:</content>
</paragraph>
<paragraph>St. Johnâ€™s wort <br/>(<content stylecode="italics">Hypericum perforatum</content>)</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>May lead to loss of virologic response and possible resistance to RESCRIPTOR or to the class of NNRTIs.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">HMG-CoA reductase inhibitors:</content>
</paragraph>
<paragraph>Lovastatin, simvastatin</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Potential for serious reactions such as risk of myopathy including rhabdomyolysis.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">Neuroleptic:</content>
</paragraph>
<paragraph>Pimozide</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>
<content stylecode="bold">Sedative/hypnotics:</content>
</paragraph>
<paragraph>Alprazolam, midazolam, triazolam</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.</paragraph>
</td>
</tr>
</tbody>
</table>